An Analysis of Autoimmunity through Studies of DNA Antibody Idiotypes

References

• Block S R, Winfield J B, Lockshin M D, et al. Studies of twins with systemic lupus erythematosus. Am J Med 1975; 59: 533–52
   PubMed Web of Science ®Google Scholar
• Dubois E L. Lupus erythematosus. A Review of the Current Status of Discoid and Systemic Lupus Erythematosus and their Variants.2nd ed. Univ of Southern California Press, Los Angeles 1974
   Google Scholar
• Morrow W JW, Isenberg D A. Autoimmune Rheumatic Disease. Blackwell Scientific, Oxford 1987
   Google Scholar
• Winchester R J. Genetic aspects. The Clinical Management of Systemic Lupus Erythematosus, P H Schur. Grune and Stratton, New York 1983
   Google Scholar
• Manthorpe R, Morling N, Plotz P, Ryder P, Svejgaard A, Thomsen M. HLA antigen frequencies in Sjogren's syndrome. Scand J Rheumatol 1981; 10: 124–8
   PubMed Web of Science ®Google Scholar
• Hirsch T J, Enlow R W, Bias W B, Amett F C. HLA-D related (DR) antigens in various kinds of myositis. Human Immunol 1981; 3: 181–6
   Google Scholar
• Zilko P J, Dawkins R L, Holmes K, Witt C. Genetic control of suppressor lymphocyte function to HLA-B8 DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol 1979; 14: 222–30
   Google Scholar
• Fielder A HI, Walport M J, Batchelor J R, et al. Family study of major histocompatibility complex in patients with systemic lupus erythematosus. Importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J 1983; 286: 425–8
   PubMed Web of Science ®Google Scholar
• Isenberg D A, Shoenfeld Y, Schwartz R S. The use of hybridomas to analyse autoimmunity. Br Med Bull 1984; 40: 262–6
   Google Scholar
• Tsokos G C, Balow J E. Cellular immune responses in systemic lupus erythematosus. Prog Allergy 1984; 35: 93–161
   PubMedGoogle Scholar
• Miller K B, Schwartz R S. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med 1979; 301: 803–9
   PubMed Web of Science ®Google Scholar
• Shear H L, Wofsy D, Talal N. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL-Mp-lpr/lpr and MRL/Mp- +/+ mice. Clin Immunol Immunopathol 1983; 26: 361–9
   Google Scholar
• Amino N, Mori H, Iwatani Y, et al. High prevalence of post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 1982; 306: 849–53
   PubMed Web of Science ®Google Scholar
• El-Roeiy A, Shoenfeld Y. Autoimmunity and pregnancy. Am J Reprod Immunol 1985; 9: 25–32
   Google Scholar
• Shoenfeld Y, Piura B. Sex hormones and autoimmune diseases. Harefua 1987; 62: 192–4
   Google Scholar
• Mastaglia F. Drug-induced disorders of muscle. Br J Hosp Med 1980; 24: 8–16
   Google Scholar
• Hess E. Drug related lupus. Arthritis Rheum 1982; 25: 857
   Google Scholar
• Harris A L, Smith I E, Snaith M L. Tamoxifen-induced tumour regression associated with dermatomyositis. Br Med J 1982; 284: 1674–5
   PubMedGoogle Scholar
• Homsy J, Morrow W JW, Levy J A. Nutrition and autoimmunity: a review. Clin Exp Immunol 1986; 65: 473–88
   PubMed Web of Science ®Google Scholar
• Isenberg D A, Maddison P, Swana G, et al. Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other gram-negative infections. Clin Exp Immunol 1987; 67: 507–15
   Google Scholar
• Stefansson K, Dieperink M D, Richman D P, Gomez C M, Martin L S. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med 1985; 321: 221–3
   Google Scholar
• Shoenfeld Y, Vilner Y, Coates A RM, et al. Monoclonal anti-TB antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 1986; 66: 255–61
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Cohen I R. Infection and autoimmunity. The Antigens, M Sela. Academic Press, FloridaUSA, in press
   Google Scholar
• Shoenfeld Y, Rauch J, Massicotte H, et al. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med 1983; 308: 414–20
   PubMed Web of Science ®Google Scholar
• Varticouski L, Pick Al, Schattner A, Shoenfeld Y. Anti-platelet and anti-DNA IgM in Waldenstrom macroglobulinaemia and ITP. Am J Haematol, in press
   Google Scholar
• André Schwartz J, Datta S K, Shoenfeld Y, Isenberg D A, Schwartz R S. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol 1984; 31: 261–71
   Google Scholar
• Shoenfeld Y, Smorodinsky N I, Lavie G, Hazaz B, Joshua H, Pinkhas J. Human lupus monoclonal autoantibodies bind to Raji cells. Immunol Lett 1985; 11: 121–6
   Google Scholar
• Carroll P, Stafford D, Schwartz R S, Stollar B D. Murine monoclonalantibodies bind to endogenous bacteria. J. Immunol 1985; 135: 1086–90
   PubMed Web of Science ®Google Scholar
• Janoff A S, Rauch J. The structural specificity of antiphospholipid antibodies in autoimmune disease. Chem Phys Lipids 1986; 40: 315–32
   PubMedGoogle Scholar
• Shoenfeld Y, Isenberg D A, Rauch J, Madaio M P, Stollar B D, Schwartz R D. Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med 1983; 158: 718–730
   PubMed Web of Science ®Google Scholar
• Isenberg D A, Shoenfeld Y, Madaio M P, et al. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 1984; ii: 417–22
   Google Scholar
• Isenberg D A, Colaco C B, Dudeney C, Todd-Pokropek A, Snaith M L. A study of the relationship between Anti-DNA antibody idiotypes and anti-cardiolipin antibodies with disease activity in systemic lupus erythematosus. Medicine (Balt) 1986; 63: 450–458
   Google Scholar
• Isenberg D A, Shoenfeld Y, Walport M, et al. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of lupus patients and their relatives. Arthritis Rheum 1985; 28: 999–1007
   PubMed Web of Science ®Google Scholar
• Dudeney C, Shoenfeld Y, Rauch J, et al. A study of anti-poly(ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members. Ann Rheum Dis 1986; 45: 502–507
   PubMedGoogle Scholar
• Solomon G, Schiffenbauer J, Keiser H D, Diamond B. Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1983; 80: 850–4
   PubMed Web of Science ®Google Scholar
• Halpern R, Davidson A, Lazo Solomon G, Lahita R, Diamond B. Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members. J Clin Invest 1985; 76: 731–6
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Brill S, Weinberger A, Pinkhas J, Isenberg D A. High levels of a common anti-DNA idiotype (16/6), a genetic marker for SLE. Acta Haemat 1986; 76: 107–109
   Google Scholar
• Schattner A, Miller K B, Kaburaki Y, Schwartz R S. Suppressor cell function and anti-DNA antibody idiotypes in the serum of SLE patients and their first degree relatives. Clin Immunol Immunopathol 1986; 41: 417–26
   Google Scholar
• Steinberg A D. Systemic lupus erythematosus. Textbook of Medicine.16th edn, J B Wyngaarden, L H Smith. Saunders, Philadelphia 1982; 1924–31
   Google Scholar
• Onodera T, Ray V R, Melez K A, Suzuki H, Toniolo A, Notkins A L. Virus induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 1982; 297: 66–8
   PubMed Web of Science ®Google Scholar
• Friedman R M, Vogel S N. Interferons with special emphasis on the immune system. Advances in Immunology 1983; 34: 97–140
   PubMed Web of Science ®Google Scholar
• Green J A, Charette A P, Yeh T J, Smith C B. Presence of interferon in acute and convalescent phase sera of humans with influenza-like disease of undetermined etiology. J Infect Dis 1982; 145: 837–41
   Google Scholar
• Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6: 131–6
   PubMedGoogle Scholar
• Steinberg A D. (Moderator) Systemic lupus erythematosus: insights from animal models. Ann Intern Med 1984; 100: 714–27
   PubMed Web of Science ®Google Scholar
• Adam C, Thoua Y T, Ronco P, Verroust P, Tovey M, Morel-Maroger L. The effect of endogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) Fl mice. Clin Exp Immunol 1980; 40: 373–82
   PubMed Web of Science ®Google Scholar
• Engelmann E G, Sonnenfeld G, Dauphinee M, et al. Treatment of NZB/NZW F1 hybrid mice with mycobacterium bovis strain BCG or type II interferon preparations accelerates disease. Arthritis Rheum 1981; 24: 1396–1402
   Google Scholar
• Gresser I. Can interferon induce disease?. Interferon 4, I Gresser. Academic Press, London 1982; 95–127
   Google Scholar
• Schattner A, Duggan D, Naparstek Y, Schwartz R S. Effects of interferon on the expression of a lupus idiotype in normal humans. Clin Immunol Immunopathol 1986; 38: 327–336
   PubMedGoogle Scholar
• Shoenfeld Y, Vilner Y, Reshef T, et al. Increased presence of common SLE anti-DNA idiotypes (16/6 ID; 32/15 ID) is induced by procainamide. J Clin Immunol, in press
   Google Scholar
• Shoenfeld Y, Ben-Yehuda O, Naparstek Y, et al. The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol 1986; 6: 194–203
   PubMed Web of Science ®Google Scholar
• Naparstek Y, Duggan D, Schattner A, et al. Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med 1985; 161: 1525–8
   PubMed Web of Science ®Google Scholar
• El Roiey A, Sela I, Isenberg D A, et al. The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) and anti-polynucleotide activity. Clin Exp Immunol 1987; 67: 505–15
   Google Scholar
• El-Roiey A, Gross W L, Ludemann J, Isenberg D A, Shoenfeld Y. Preferential secretion of a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by normal mononuclear cells following stimulation with Klebsiella pneumoniae. Immunol Lett 1986; 12: 313–9
   PubMedGoogle Scholar
• Datta S K, Naparastek Y, Schwarts R S. In vitro production of an anti-DNA idiotype by lymphocytes of normal subjects and patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1986; 38: 302–8
   PubMedGoogle Scholar
• Sela O, El-Roiey A, Isenberg D A, et al. A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 1987; 30: 50–6
   PubMed Web of Science ®Google Scholar
• Isenberg D A, Collins C. Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue bound immunoglobulins from lupus patients. J Clin Invest 1985; 76: 287–94
   PubMed Web of Science ®Google Scholar
• Isenberg D A, Dudeney C, Wojnaruska F, Bhogal B S, Rauch J, Naparstek Y, Duggan D, Schattner A. Detection of cross-reactive anti-DNA antibody idiotypes on tissue bound immunoglobulins from skin biopsies of lupus patients. J Immunol 1985; 135: 261–4
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Segel G, Segol O, et al. Detection of antibodies to total histones and their subfractions in SLE patients and their asymptomatic relatives. Arthritis Rheum 1987; 30: 169–75
   PubMedGoogle Scholar
• El-Roiey A, Shoenfeld Y, Gleicher N, Isenberg D A, Kennedy R C. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with SLE. Clin Exp Immunol 1987; 68: 528–34
   Google Scholar
• Lefvert A K, Osterman P O. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetyl-choline receptor antibodies in 17 children. Neurology 1983; 33: 113–8
   Google Scholar
• Cohen I R, Cooke A. Natural autoantibodies might prevent autoimmune disease. Immunol Today 1986; 7: 363–5
   PubMedGoogle Scholar